-
Parents, physicians and the public attempting to make sense of the controversy about antidepressants are torn between unproven claims and counter-claims about the drugs’ benefits and risks.
-
Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug
An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials.
-
Brain Images–What Do They Mean?
Benedict Carey of The New York Times reports with a degree of healthy skepticism about the latest scientific hoopla: Neuroscientists’ infatuation with brain imaging techniques.
-
When Trust in Doctors Erodes
"Soon, intuition and the personal experience of friends and family may seem as trustworthy as advice from a doctor in diagnosing an illness or judging a treatment."
-
Polypharm & New Antipsychotics Not More Beneficial-Just More Expensive
"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost."
-
Antipsychotic Drugs are Killing patients_Brit J Psychiatry
A major 17-year follow up study published in the British Journal of Psychiatry [1] found a 2.84 times (95% CI 2.06–3.90) increased risk of mortality in people with schizophrenia compared to those not so diagnosed, and with each addition of a neuroleptic (antipsychotic) drug, the risk increased another 2.50.
-
State Laws to Force Drugs on Mental Paitients Sparks Growing Debate_WSJ
"Mr. Stanley says he has donated nearly $300 million — including about $35 million in 2005 — to Dr. Torrey’s efforts, the bulk of it for research at universities and start-up drug companies."